A new study has revealed insights into how inhibiting a cellular molecule could help thwart the onset of alcohol-related pancreatic cancer, potentially adding to doctors' understanding of how booze ...

FDA confirmed at a July 2025 Type B meeting and in the subsequent meeting minutes that eGFR slope is an acceptable surrogate endpoint for accelerated approval of rilparencel in patients with type 2 di ...